购物车
- 全部删除
- 您的购物车当前为空
PD-L1degrader-2 (Compound B3) 作为一种口服有效的AUTAC降解剂,通过自噬-溶酶体途径有效降解PD-L1,其DC50值为0.5 μM。此化合物能够有效抑制PD-1/PD-L1相互作用,具有IC50值为22.8 nM。同时,PD-L1degrader-2能上调Atg9b、Lamp1和Mitf的表达,激活自噬溶酶体系统,且在CT26小鼠模型中显示出明显的抗肿瘤活性。
PD-L1degrader-2 (Compound B3) 作为一种口服有效的AUTAC降解剂,通过自噬-溶酶体途径有效降解PD-L1,其DC50值为0.5 μM。此化合物能够有效抑制PD-1/PD-L1相互作用,具有IC50值为22.8 nM。同时,PD-L1degrader-2能上调Atg9b、Lamp1和Mitf的表达,激活自噬溶酶体系统,且在CT26小鼠模型中显示出明显的抗肿瘤活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | PD-L1degrader-2 (Compound B3) is an orally effective AUTAC degrader that degrades PD-L1 via the autophagy-lysosome pathway with a DC50 of 0.5 μM. It inhibits the interaction between PD-1 and PD-L1, with an IC50 of 22.8 nM. PD-L1degrader-2 upregulates the expression of Atg9b, Lamp1, and Mitf, activating the autophagy-lysosome system. It exhibits antitumor activity in the CT26 mouse model. |
分子量 | 780.91 |
分子式 | C45H48N8O5 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容